Contact information Verified work emails, personal emails, and direct dials — unlocked in one click.
Work email
•••••@trialx.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••
Free to start · No credit card required
Current company Trialx
IT Services and IT Consulting · 46 employees · Founded 2008 · Tarrytown, New York, United States
What is TrialX? TrialX is a clinical research and space health informatics company headquartered in New York City. From launching the first clinical trials app on Google Health in 2008, to powering online patient recruitment and research data collection for space missions, TrialX is empowering clinical research here on earth and beyond. Our Solutions: Enterprise Patient Recruitment: With our award-winning patient recruitment management platform – we are helping thousands of patients find relevant trials and get connected to research teams seamlessly. Recently, we announced the launch of a new Diversity, Equity and Inclusion (DEI) toolkit in the platform – that will have a wide ranging impact by bringing diversity and inclusion in the front and center of patient recruitment workflows. Our platform serves as a central system for patient recruitment operations at major pharmaceutical sponsors, large academic research centers and patient advocacy groups, which includes a clinical trials finder, study website builder, pre-screeners, referral tracking, volunteer registry and real-time analytics. Remote Data Collection: TrialX\'s fully scalable end-to-end Remote Data Collection platform powers hybrid/virtual global clinical trials. Clinical trial teams can manage both sites and patients within the system. Key features include eConsent, Pre-screeners, eCOA/ePRO, Cognitive Tasks, Virtual Visits, Push/SMS Reminders, Wearable Integrations, and a powerful analytics dashboard to monitor participants and unlock insights. Online Talk Shows: CureTalks raises clinical trials awareness by bringing patients, patient advocates and researchers on the same platform. Visit trialx.com to learn more.